Regulation of progesterone receptor messenger ribonucleic acid and protein levels in MCF-7 cells by estradiol: analysis of estrogen's effect on progesterone receptor synthesis and degradation - PubMed (original) (raw)
Regulation of progesterone receptor messenger ribonucleic acid and protein levels in MCF-7 cells by estradiol: analysis of estrogen's effect on progesterone receptor synthesis and degradation
A M Nardulli et al. Endocrinology. 1988 Mar.
Abstract
The human breast cancer cell line MCF-7 responds to estrogens with increased progesterone receptor (PR) levels. In this study, we use dense amino acid density shift analyses to address directly the question of whether estrogen increases PR levels in MCF-7 cells by altering rates of receptor synthesis and/or degradation. Using different concentrations of estradiol (E2), which achieve PR levels that are half-maximal (3 X 10(-11) M F2) or maximal (6 X 10(-11) M E2), we have done sucrose gradient density shift analyses using dense (15N, 13C, 2H) amino acid incorporation to study rates of PR synthesis and degradation. These studies reveal a nonlinear loss of preexisting normal density receptor with time. From kinetic modeling analyses, equivalent rates of degradation are estimated for PR whether maximal or half-maximal levels are maintained, indicating that the major effect of E2 on PR content is to increase the rate of PR synthesis while leaving the degradation rate unaltered. The E2-stimulated increase in PR protein is also associated with increased levels of PR mRNA, as demonstrated by the use of a human PR cDNA probe. These density shift data provide evidence that the increased PR levels after estrogen exposure in MCF-7 cells are the result of an increased rate of receptor synthesis, rather than modulation of the rate of receptor degradation.
Similar articles
- Autologous down-regulation of messenger ribonucleic acid and protein levels for estrogen receptors in MCF-7 cells: an inverse correlation to progesterone receptor levels.
Ree AH, Landmark BF, Eskild W, Levy FO, Lahooti H, Jahnsen T, Aakvaag A, Hansson V. Ree AH, et al. Endocrinology. 1989 May;124(5):2577-83. doi: 10.1210/endo-124-5-2577. Endocrinology. 1989. PMID: 2651098 - Hormonal regulation of estrogen receptor messenger ribonucleic acid in T47Dco and MCF-7 breast cancer cells.
Berkenstam A, Glaumann H, Martin M, Gustafsson JA, Norstedt G. Berkenstam A, et al. Mol Endocrinol. 1989 Jan;3(1):22-8. doi: 10.1210/mend-3-1-22. Mol Endocrinol. 1989. PMID: 2915647
Cited by
- Fertility treatment is associated with multiple meningiomas and younger age at diagnosis.
Shahin MN, Magill ST, Dalle Ore CL, Viner JA, Peters PN, Solomon DA, McDermott MW. Shahin MN, et al. J Neurooncol. 2019 May;143(1):137-144. doi: 10.1007/s11060-019-03147-6. Epub 2019 Mar 13. J Neurooncol. 2019. PMID: 30868355 Free PMC article. - Sensitivity and Isoform Specificity of 18F-Fluorofuranylnorprogesterone for Measuring Progesterone Receptor Protein Response to Estradiol Challenge in Breast Cancer.
Salem K, Kumar M, Yan Y, Jeffery JJ, Kloepping KC, Michel CJ, Powers GL, Mahajan AM, Fowler AM. Salem K, et al. J Nucl Med. 2019 Feb;60(2):220-226. doi: 10.2967/jnumed.118.211516. Epub 2018 Jul 20. J Nucl Med. 2019. PMID: 30030339 Free PMC article. - Insulin-like growth factor receptor and sphingosine kinase are prognostic and therapeutic targets in breast cancer.
Ochnik AM, Baxter RC. Ochnik AM, et al. BMC Cancer. 2017 Dec 5;17(1):820. doi: 10.1186/s12885-017-3809-0. BMC Cancer. 2017. PMID: 29207959 Free PMC article. - Progesterone Receptor Isoform Ratio: A Breast Cancer Prognostic and Predictive Factor for Antiprogestin Responsiveness.
Rojas PA, May M, Sequeira GR, Elia A, Alvarez M, Martínez P, Gonzalez P, Hewitt S, He X, Perou CM, Molinolo A, Gibbons L, Abba MC, Gass H, Lanari C. Rojas PA, et al. J Natl Cancer Inst. 2017 Jul 1;109(7):djw317. doi: 10.1093/jnci/djw317. J Natl Cancer Inst. 2017. PMID: 28376177 Free PMC article. - The association between reproductive and hormonal factors and ovarian cancer by estrogen-α and progesterone receptor status.
Shafrir AL, Rice MS, Gupta M, Terry KL, Rosner BA, Tamimi RM, Hecht JL, Tworoger SS. Shafrir AL, et al. Gynecol Oncol. 2016 Dec;143(3):628-635. doi: 10.1016/j.ygyno.2016.09.024. Epub 2016 Oct 5. Gynecol Oncol. 2016. PMID: 27720231 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous